Friday, August 7, 2015

This week in ePharma: The Future is here: FDA o'kays the 3-D printed drug and more!

Pin It Now!
The Future is here! The biotech industry continues to explore the possibilities of 3-D print technology, and one of its latest developments is a 3-D-printed pill.

FDA approves the first 3D-printed drug
FDA gives a go to the first ever 3-D printed drug against epilepsy called SPRITAM. Some of the benefits of a 3-D-printed drug are the ability to manufacture the drugs with high dose of the active element levetiracetam in one dosage and to produce pills identical to one another making it easier for patients to swallow. As NPR stated the drug is expected to hit the market in 2016.

Yelp partners with ProPublica, to provide Yelp's users with with healthcare statistics on hospitals and clinics around in the US. ProPublica is a nonprofit organization based NYC whose mission is "Journalism in the Public Interest." ProPublica does investigative reporting in many fields include healthcare. What Yelp is aiming for is to be able to better navigate its users and help them make more conscious decisions regarding their health. The statistics will include such categories as the number of beds available at a hospital, wait times
and more.

The Next Web in its article "Can tech help overcome addiction?" explores a new trend in mobile app development - mobile health apps focused on creating bonds between people with similar challenges such as sobriety, past drug addiction and others. It's been documented that there's a strong relationship between isolation and addiction, therefore more and more tech start ups shift their attention toward building mobile health apps that provide support from communities of like-minded. One of such mobile health apps is called My Sober Life that aims to support young people in their path to sobriety.

It's been reported that Hospira's Symbiq Infusion System (an IV pump) has a security loop that allows unauthorized users to access the equipment remotely and control the dosage of drugs delivered. And while no security breaches has been revealed, the FDA issued a safety alert urging hospitals to stop using the system as a prevention measure.


Stay tuned for our weekly news round up! 

Subscribe to our Blog or follow us on Twitter: @epharma


About the author: Ksenia Newton, a Digital Marketing Assistant at IIR USA, Pharma Division, who works on various aspects of the industry including social media, marketing analysis and media. She can be reached at
Post a Comment